Literature DB >> 17690899

Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells.

Walter Krugluger1, Stefan Seidel, Kerstin Steindl, Susanne Binder.   

Abstract

BACKGROUND: Culture of retinal pigment epithelium (RPE) cells might be a future option in the therapy of various degenerative retinal diseases. However, the molecular changes which occur during in vitro expansion of RPE cells during culture are not fully elucidated. The aim of this study was to evaluate molecular changes in the RPE cell line ARPE-19 after stimulation with different growth factors.
METHODS: Cultured ARPE-19 cells were stimulated for 72 hours with rh-EGF, rh-IGF-1, rh-VEGF or rh-bFGF, and transcriptional changes of the differentiation markers cytokeratin 18 and RPE65 and of the key molecules of the wnt pathway, beta-catenin, and glycogen synthase kinase-3 (GSK-3) were evaluated by real time RT-PCR.
RESULTS: We found a significant decrease of cytokeratin 18 and RPE65 transcription after stimulation with rh-EGF (0.47 +/- 0.42 and 0.32 +/- 0.57-fold, respectively; p < 0.05). A significant reduction of beta-catenin and GSK-3 mRNA was found in ARPE-19 cells stimulated with rh-IGF-1 (0.61 +/- 0.25 and 0.52 +/- 0.02-fold, respectively) or rh-EGF (0.55 +/- 0.19 and 0.76 +/- 0.26-fold, respectively). No changes of beta-catenin mRNA were observed after stimulation with rh-VEGF or bFGF.
CONCLUSION: Our data suggest an inhibition of the beta-catenin-pathway in ARPE-19 cells by IGF-1 and EGF, suggesting that ARPE-19 cell proliferation is, at least in part, driven by the beta-catenin pathway. Furthermore, induction of proliferation by EGF results in a loss of differentiation markers in these cells. Maintaining the RPE phenotype is still one of the main problems for RPE- transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690899     DOI: 10.1007/s00417-007-0635-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 3.  Signal transduction by the Wnt family of ligands.

Authors:  T C Dale
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

4.  Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.

Authors:  Q Wang; Y Zhou; X Wang; B M Evers
Journal:  Oncogene       Date:  2006-01-05       Impact factor: 9.867

5.  Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial.

Authors:  Susanne Binder; Ilse Krebs; Ralf-Dieter Hilgers; Ali Abri; Ulrike Stolba; Adele Assadoulina; Lukas Kellner; Boris V Stanzel; Christian Jahn; Hans Feichtinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

6.  The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.

Authors:  D A Cross; D R Alessi; J R Vandenheede; H E McDowell; H S Hundal; P Cohen
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

7.  EGFR signaling to p120-catenin through phosphorylation at Y228.

Authors:  Deborah J Mariner; Michael A Davis; Albert B Reynolds
Journal:  J Cell Sci       Date:  2004-03-02       Impact factor: 5.285

8.  MAP kinase and beta-catenin signaling in HGF induced RPE migration.

Authors:  Gregory I Liou; Suraporn Matragoon; Sara Samuel; M Ali Behzadian; Nai-Tse Tsai; Xiaolin Gu; Penny Roon; D Margaret Hunt; Richard C Hunt; Ruth B Caldwell; Dennis M Marcus
Journal:  Mol Vis       Date:  2002-12-20       Impact factor: 2.367

9.  A functional profile of gene expression in ARPE-19 cells.

Authors:  Rajesh K Sharma; William E Orr; Allyson D Schmitt; Dianna A Johnson
Journal:  BMC Ophthalmol       Date:  2005-11-01       Impact factor: 2.209

10.  Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition.

Authors:  Robin E Bachelder; Sang-Oh Yoon; Clara Franci; Antonio García de Herreros; Arthur M Mercurio
Journal:  J Cell Biol       Date:  2005-01-03       Impact factor: 10.539

View more
  5 in total

1.  Epidermal growth factor: the driving force in initiation of RPE cell proliferation.

Authors:  Kerstin Steindl-Kuscher; Michael E Boulton; Paulina Haas; Astrid Dossenbach-Glaninger; Hans Feichtinger; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  DKK1 inhibits proliferation and migration in human retinal pigment epithelial cells via the Wnt/β-catenin signaling pathway.

Authors:  Jinzi Zhou; Jian Jiang; Shuhong Wang; Xiaobo Xia
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

Review 3.  Epithelial phenotype and the RPE: is the answer blowing in the Wnt?

Authors:  Janice M Burke
Journal:  Prog Retin Eye Res       Date:  2008-08-19       Impact factor: 21.198

4.  Fisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression.

Authors:  Hung-Yu Lin; Yong-Syuan Chen; Kai Wang; Hsiang-Wen Chien; Yi-Hsien Hsieh; Shun-Fa Yang
Journal:  Mol Vis       Date:  2017-12-10       Impact factor: 2.367

5.  Microbioreactor array screening of Wnt modulators and microenvironmental factors in osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Jessica E Frith; Drew M Titmarsh; Harish Padmanabhan; Justin J Cooper-White
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.